openPR Logo
Press release

Antineoplastic Agents Market Is Expected to Reach a Valuation of US$ 286.49 Billion By 2033

11-22-2023 02:07 PM CET | Health & Medicine

Press release from: Fact.MR

Antineoplastic Agents Market Is Expected to Reach a Valuation

The market for antineoplastic agents is expected to reach a value of US$ 126.71 billion in 2023 and grow at an estimated CAGR of 8.5% between 2023 and 2033. Cancer is treated with pharmaceuticals known as antineoplastic agents or drugs. Antineoplastic drugs sometimes go by the labels chemotherapy, cytotoxic, and anticancer. These drugs are available as liquids or pills. People are more aware of cancer and its therapies as it becomes a more widespread problem worldwide.

The expansion of the global healthcare infrastructure is predicted to support market growth over the course of the forecast period. The development of anti-neoplastic medicines is being hampered by a number of problems, including prohibitive drug costs and onerous product approval rules.

๐——๐—ผ๐˜„๐—ป๐—น๐—ผ๐—ฎ๐—ฑ ๐—ฎ ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—–๐—ผ๐—ฝ๐˜† ๐—ผ๐—ณ ๐—ง๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8071?PJ

Biological agents are gaining traction since the outbreak of COVID-19 and high developments are seen in the biological treatment of cancer disorders. To deliver advanced treatment to target patients, various medical researchers are concentrating on nanotechnology. The immune system of the patient is used in biological therapy to treat cancer while protecting healthy cells.

North America and Europe are dominating regional markets for antineoplastic agent producers due to the rising cases of cancers and growing medical tourism. While the Asia Pacific antineoplastic agents market is expected to increase at the fastest pace during the forecast period due to the rapidly developing healthcare industry, key market players are planting their manufacturing units in the region to earn more income.

๐—ž๐—ฒ๐˜† ๐—ง๐—ฎ๐—ธ๐—ฒ๐—ฎ๐˜„๐—ฎ๐˜†๐˜€ ๐—ณ๐—ฟ๐—ผ๐—บ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฆ๐˜๐˜‚๐—ฑ๐˜†

The global market for antineoplastic agents is projected to reach US$ 286.49 billion by 2033.

Germany's market is predicted to expand at a CAGR of 6% during the forecast period.

Demand for antineoplastic agents in China is expected to rise at an impressive CAGR of 12% during the forecast period.

The demand for biological agents is predicted to rise at a high CAGR of 9% from 2023 to 2033.

๐—ช๐—ถ๐—ป๐—ป๐—ถ๐—ป๐—ด ๐—ฆ๐˜๐—ฟ๐—ฎ๐˜๐—ฒ๐—ด๐˜†

Key manufacturers of antineoplastic agents are fully focused on developing advanced drugs, for which they are highly investing in R&D activities. This will not only help them to gain more revenue but also to reach dominating market position. Other strategies such as acquisitions, mergers and collaborations are adopted by manufacturers of antineoplastic agents.

The acquisition of Tidal Therapeutics, a pre-clinical biotech firm in charge of creating an mRNA-based research platform, by Sanofi was announced in April 2021. With the aid of this acquisition, Sanofi will be able to increase the scope of its research in the fields of oncology, immunology, and other diseases.

๐—ž๐—ฒ๐˜† ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ ๐—ถ๐—ป ๐—”๐—ป๐˜๐—ถ๐—ป๐—ฒ๐—ผ๐—ฝ๐—น๐—ฎ๐˜€๐˜๐—ถ๐—ฐ ๐—”๐—ด๐—ฒ๐—ป๐˜๐˜€ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜

AbbVie
Abraxis
AstraZeneca
Baekdu Mountain Pharmaceutical
Baida Pharmaceutical
Bayer
Biogen Idec
BMS
Celgene
CTTQ
Eisai

๐—ž๐—ฒ๐˜† ๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—ผ๐—ณ ๐—”๐—ป๐˜๐—ถ๐—ป๐—ฒ๐—ผ๐—ฝ๐—น๐—ฎ๐˜€๐˜๐—ถ๐—ฐ ๐—”๐—ด๐—ฒ๐—ป๐˜๐˜€ ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต

๐—•๐˜† ๐—ฃ๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜ :
Chemotherapeutic Agents
Biological/Immunotherapeutic Agents
Personalized Medicines
Alkylating and Alkylating-like Agents
Hormonal Agents, Miscellaneous Agents

๐—•๐˜† ๐—˜๐—ป๐—ฑ ๐—จ๐˜€๐—ฒ๐—ฟ :
Hospitals
Clinics
Cancer Rehabilitation Centers
Ambulatory Surgical Centers

๐—•๐˜† ๐—ฅ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป:
North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA

๐— ๐—ผ๐—ฟ๐—ฒ ๐—ฉ๐—ฎ๐—น๐˜‚๐—ฎ๐—ฏ๐—น๐—ฒ ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€ ๐—ผ๐—ป ๐—ข๐—ณ๐—ณ๐—ฒ๐—ฟ

Fact.MR, in its new offering, presents an unbiased analysis of the global antineoplastic agents market, presenting historical demand data (2018-2022) and forecast statistics for the period of 2023-2033.

The study divulges essential insights on the market on the basis of product (chemotherapeutic agents, biological/immunotherapeutic agents, personalized medicines, alkylating & alkylating-like agents, hormonal agents, miscellaneous agents) and end user (hospitals, clinics, cancer rehabilitation centers, ambulatory surgical centers), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).

๐—š๐—ฒ๐˜ ๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ป ๐˜๐—ต๐—ถ๐˜€ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฆ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8071?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antineoplastic Agents Market Is Expected to Reach a Valuation of US$ 286.49 Billion By 2033 here

News-ID: 3298163 • Views: โ€ฆ

More Releases from Fact.MR

USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Microbiome Skincare Products in USA Outlook 2025-2035: Key Develo โ€ฆ
The U.S. microbiome skincare market is projected to experience rapid, data-driven growth over the next decade, driven by rising consumer awareness, ingredient innovation, and the integration of personalized diagnostics. Analysts estimate the U.S. microbiome skincare segment at approximately USD 0.13 billion in 2025, with a projected increase to USD 0.35 billion by 2035, representing a compound annual growth rate (CAGR) of 10.4%. To access the complete data tables and in-depth insights,โ€ฆ
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Lubricants in USA Outlook 2025-2035: Key Developments and Future โ€ฆ
The U.S. lubricants market is projected to experience steady growth through 2035, driven by shifts in mobility, industrial demand, and sustainability trends. The market was valued at approximately $41.2 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 2.5%, reaching $52 billion by 2035. To access the complete data tables and in-depth insights, request a Discount On The Report here: https://www.factmr.com/connectus/sample?flag=S&rep_id=12463 โ€ฆ
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: Key Developments and Future Scope
European Demand for Intermodal Freight Transportation in UK Outlook 2025-2035: K โ€ฆ
"Demand for intermodal freight transport connecting the UK and continental Europe is projected to grow at a CAGR of 6.8% between 2025 and 2035, driven by rising trade volumes, decarbonization mandates, and digital logistics innovations. The intermodal market, encompassing rail, short-sea shipping, and last-mile road delivery, is expected to handle over 18 million TEUs (twenty-foot equivalent units) annually by 2035, up from 10.2 million TEUs in 2025. To access the completeโ€ฆ
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Future Scope
USA Demand for Hydroxyapatite in USA Outlook 2025-2035: Key Developments and Fut โ€ฆ
The United States hydroxyapatite (HAp) market is projected to experience sustained, data-driven growth from 2025 through 2035, fueled by rising clinical demand, technological innovation, and expanded applications in regenerative medicine. Market modeling indicates that U.S. consumption of hydroxyapatite will nearly double over the next decade, with strong adoption in orthopedic, dental, and advanced biomaterial sectors. To access the complete data tables and in-depth insights, request a Discount On The Report here:โ€ฆ

All 5 Releases


More Releases for Agents

Appy Pie Agents Announces 7-Day Free Trial for Building Custom AI Agents
Appy Pie Agents now offers a 7-day free trial to build custom AI agents, with no credit card required and available for a limited time. NOIDA, Uttar Pradesh, India - November 17, 2025 - Appy Pie Agents, a no-code AI agent builder [https://www.appypieagents.ai/] platform, has announced a 7-day free trial that allows users to create their own AI agents without any upfront payment. As part of this limited period offer, usersโ€ฆ
AGENTS CO., LTD. Launches Early TDAC Application Made Simple by AGENTS
AGENTS CO., LTD. has launched a dedicated platform for submitting Thailand Digital Arrival Cards (TDAC), built specifically to support travel agents, tour operators, and travel service providers managing group travel. The system is designed to eliminate the stress of last-minute filings and make the TDAC process faster, more flexible, and more reliable for everyone involved. One of the platform's standout features is its support for full pre-submission edits, allowing agents toโ€ฆ
Anti-parathyroid Agents Market - Harmony Within Reach: Anti-parathyroid Agents D โ€ฆ
Newark, New Castle, USA: The "Anti-parathyroid Agents Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Anti-parathyroid Agents Market: https://www.growthplusreports.com/report/antiparathyroid-agents-market/8935 This latest report researches the industry structure, sales, revenue,โ€ฆ
Tocolytic Agents Market - Preserving Pregnancy, Ensuring Wellbeing: Tocolytic Ag โ€ฆ
Newark, New Castle, USA - new report, titled Tocolytic Agents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tocolytic Agents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tocolytic Agents market. The report offers an overview of the market, whichโ€ฆ
uParcel Launches 'Agents Benefits' for their Delivery Agents
uParcel announced today the launch of Agent Benefits for new and current verified delivery agents which aims to expand the existing network of Delivery Agents Team. Through the Agents Benefits launches, uParcel hopes to increase the number of delivery agent signups to fulfil the increasing numbers of delivery jobs. uParcel believes in long-term investment in the delivery agents' job welfare and well-being. "We're not looking for a short-term partnership withโ€ฆ
Global Packaging Additives Market - By product (Antimicrobial Agents, Antifog Ag โ€ฆ
Market Research Reports Search Engine (MRRSE) has recently updated its massive report catalog by adding a fresh study titled โ€œGlobal Packaging Additives Market - In-Depth Analysis with Booming Trends Supporting Growth and Forecast till 2028โ€. This business intelligence study encapsulates vital details about the market current as well as future status during the mentioned forecast period of 2028. The report also targets important facets such as market drivers, challenges, latestโ€ฆ